Page last updated: 2024-11-04

tetracaine and Corneal Neovascularization

tetracaine has been researched along with Corneal Neovascularization in 1 studies

Tetracaine: A potent local anesthetic of the ester type used for surface and spinal anesthesia.
tetracaine : A benzoate ester in which 4-N-butylbenzoic acid and 2-(dimethylamino)ethanol have combined to form the ester bond; a local ester anaesthetic (ester caine) used for surface and spinal anaesthesia.

Corneal Neovascularization: New blood vessels originating from the corneal blood vessels and extending from the limbus into the adjacent CORNEAL STROMA. Neovascularization in the superficial and/or deep corneal stroma is a sequel to numerous inflammatory diseases of the ocular anterior segment, such as TRACHOMA, viral interstitial KERATITIS, microbial KERATOCONJUNCTIVITIS, and the immune response elicited by CORNEAL TRANSPLANTATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Georgakopoulos, CD1
Vasilakis, P1
Makri, OE1
Beredima, E1
Pharmakakis, N1

Other Studies

1 other study available for tetracaine and Corneal Neovascularization

ArticleYear
Subconjunctival bevacizumab for corneal neovascularization secondary to topical anesthetic abuse.
    Cutaneous and ocular toxicology, 2011, Volume: 30, Issue:4

    Topics: Anesthetics, Local; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Corneal

2011